#ai

At the World Economic Forum in Davos, OpenAI's CEO Sam Altman highlighted the urgent need for a significant energy breakthrough to sustain the development of artificial intelligence (AI).

Sony's research team has pioneered an artificial intelligence system designed to parse dialogues and autonomously craft fictional identities for non-player characters. This technology is set to overhaul the conventional methods of secondary character development.

Microsoft announced the launch of Copilot Pro, a premium version of its AI-driven Copilot tool, priced at $20 per month. This offering brings features once reserved for corporate clients to a broader audience.

The World Economic Forum's recent global risks report places AI-generated disinformation at the top of short-term (up to two years) threats, surpassing even climate change and wars

Malefactors are not resting, leveraging artificial intelligence (AI) and the likenesses of renowned crypto enthusiasts for deceptive schemes.

Microsoft and Vodafone have jointly announced a landmark 10-year strategic partnership, with an investment of $1.5 billion dedicated to advancing artificial intelligence and cloud-based services.

OpenAI has announced its proactive measures to prevent the misuse of AI during the upcoming 2024 elections, likely referring to the U.S. presidential election without explicitly stating so.

OpenAI, a company specializing in artificial intelligence development, has begun negotiations with top media outlets including Fox, Time, and CNN. The talks are centered around obtaining a license to use their content for AI model training. This strategy is intended to preemptively address any future copyright infringement concerns.

The United States Screen Actors Guild-American Federation of Television and Radio Artists (SAG-AFTRA) and Replica Studios, a company focused on AI-based voice technologies, have announced a partnership at the CES 2024 expo.

A team of medical researchers at Mount Sinai conducted a study on AI chatbots, evaluating their effectiveness as autonomous practitioners of evidence-based medicine.

Shares of the American firm LungLife AI, engaged in developing AI-driven diagnostic techniques for lung cancer, have seen a notable increase, peaking at a 60% rise. This boost came in the wake of publishing successful results from their LungLB test.